(Updated - November 29, 2016 8:15 AM EST)Barclays upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from Equalweight to Overweight with a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE